200512_Phase II Trial Update - Successful Outcome Category: News & Announcements 2020By PharmAust12/05/2020Related postsDecember 31, Top 20 Shareholders04/01/2021December 23, PharmAust Commences MPL Manufacture for Human Clinical Trials23/12/2020December 22, PharmAust Set to Commence Phase IIb Anticancer Canine Trial22/12/2020December 21, Epichem Awarded DNDi Extension21/12/2020December 4, Issued Capital04/12/2020November 30, Top 20 Shareholders01/12/2020
